Arterial Hypertension
Conditions
Interventions
Experimental group: 409 individuals, randomly selected (randomized controlled), with open blinding, from the Basic Health Units of nine municipalities in Viçosa, MG and Viçosa health microregion. Indi
L01.224.900.685
Sponsors
Universidade Federal de Viçosa
Universidade Federal de Viçosa
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age equal to or greater than 18 years; users of the Unified Health System (SUS); diagnosis of Arterial Hypertension (AH) and/or Diabetes Mellitus (DM); accompanied by the Family Health Strategy (ESF) teams
Exclusion criteria
Exclusion criteria: Age less than 18 years old; individuals with serious medical conditions; pregnant women; smoking volunteers; history of alcohol or drug abuse; bedridden; wheelchair users
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It was expected to find a reduction in the clinical values of glycated hemoglobin in 6 months after the intervention, verified through the performance of biochemical tests and from the verification of a variation of at least 10% in the pre- and post-intervention measurements.;It was expected to find a reduction in blood pressure levels 6 months after the intervention, verified by measuring blood pressure and from the observation of a variation of at least 10% in pre- and post-intervention measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate the changes in anthropometric measurements (body weight, abdominal and calf circumference) in 6 months after the intervention, which will be verified with the aid of a scale and a body measuring tape and from the verification of a variation of at least 5 % in pre- and post-intervention measures. | — |
Countries
Brazil
Contacts
Public ContactEmily Ferreira
Universidade Federal de Viçosa
Outcome results
None listed